CHAMP T 2 Pilot of CIMT by Tele-Video
Efficacy of Constraint Induced Movement Therapy Delivered by Tele-Video for Children With Hemiplegic Cerebral Palsy
1 other identifier
interventional
10
1 country
2
Brief Summary
The CHAMP-T2 study is a pilot test of the efficacy of constraint induced movement therapy (CIMT) when delivered by tele-video in the child's home or home-like environment. This study will examine the pre-, post-intervention function a hemiparetic limb in children who have hemiplegic cerebral palsy. The purpose is to provide an effect size estimate that will inform the design of a future study that will compare tele-delivered CIMT with usual and customary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2024
CompletedStudy Start
First participant enrolled
June 27, 2024
CompletedFirst Posted
Study publicly available on registry
July 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
December 23, 2025
December 1, 2025
2.5 years
June 27, 2024
December 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Melbourne Assessment of Unilateral Upper Limb Function
Measures function of the impaired upper limb
At baseline pre-treatment and at the end of the 4-week intervention
Secondary Outcomes (3)
Assisting Hand Assessment
At baseline pre-treatment and at the end of the 4-week intervention
Pediatric Motor Activity Log
At baseline pre-treatment and at the end of the 4-week intervention
Fidelity to treatment protocol
During 4 weeks of intervention
Study Arms (1)
Intervention arm
EXPERIMENTALThis is a single arm in an open label pre- post-treatment design to estimate effect size of the intervention
Interventions
In-home Constraint induced movement therapy delivered by a therapist participating by televideo
Eligibility Criteria
You may qualify if:
- Children who have hemiplegic cerebral palsy, ages 4-10;
- hemiparesis ranging from Manual Ability Classification System (MACS) I to MACS IV;
- live within a 1.5 hour distance from therapists' worksites at the Ohio State University Wexner Medical Center in Columbus, Ohio, or the Fralin Biomedical Research Institute in Roanoke, Virginia;
- are willing to travel to these sites for two in-person assessments.
You may not qualify if:
- Previous high dose CIMT (defined as CIMT given 2 hrs per day for 10 days) in the 6 months preceding baseline assessment;
- Treatment with botulinum toxin for spasticity in the 3 months preceding baseline assessment;
- Surgery for spasticity in the 6 months preceding baseline assessment;
- Medically unstable and unable to participate in the treatment intervention;
- Child is behaviorally or cognitively impaired so unable to participate in the treatment intervention;
- Family unable to participate in tele-delivery of CIMT 5 days a week for 4 weeks;
- the caregiver available at child's treatment site during treatment times is unable to communicate with the treating therapist.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Warren Lolead
- Ohio State Universitycollaborator
- Virginia Polytechnic Institute and State Universitycollaborator
Study Sites (2)
The Ohio State University School of Health and Rehabilitation Sciences
Columbus, Ohio, 43210, United States
Virginia Tech-Fralin Biomedical Research Institute
Roanoke, Virginia, 24016, United States
Related Publications (1)
Ramey SL, DeLuca SC, Stevenson RD, Conaway M, Darragh AR, Lo W; CHAMP. Constraint-Induced Movement Therapy for Cerebral Palsy: A Randomized Trial. Pediatrics. 2021 Nov;148(5):e2020033878. doi: 10.1542/peds.2020-033878. Epub 2021 Oct 14.
PMID: 34649982BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Warren Lo, MD
Nationwide Children's Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Clinical Professor, Pediatrics and Neurology
Study Record Dates
First Submitted
June 27, 2024
First Posted
July 5, 2024
Study Start
June 27, 2024
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
June 30, 2027
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share
For this small pilot study we do not anticipate sharing individual participant data because of the difficulty of maintain subject confidentiality